|F0GBR06R8K -- India Fund|| |
INR 117.37 0.50 0.42%
The entity has beta of 0.0 which indicates the returns on MARKET and SBI Pharma are completely uncorrelated. Although it is extremely important to respect SBI Pharma Reg
current price movements, it is better to be realistic regarding the information on equity historical returns. The way of measuring future performance of any fund is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By analyzing SBI Pharma Reg technical indicators
you can today evaluate if the expected return of 0.0% will be sustainable into the future.
Risk-Adjusted Fund Performance
Over the last 30 days SBI Pharma Reg Gr has generated negative risk-adjusted returns adding no value to fund investors. Despite somewhat strong basic indicators, SBI Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short term losses for the investors.
|Fifty Two Week Low||109.74|
|Fifty Two Week High||135.50|
|Annual Report Expense Ratio||2.50%|
SBI Pharma Reg Relative Risk vs. Return Landscape
If you would invest 11,737
in SBI Pharma Reg Gr on June 20, 2019
and sell it today you would earn a total of 0.00
from holding SBI Pharma Reg Gr or generate 0.0%
return on investment over 30
days. SBI Pharma Reg Gr is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than SBI Pharma and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
SBI Pharma Market Risk Analysis
Sharpe Ratio = 0.0
Based on monthly moving average SBI Pharma is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SBI Pharma
by adding it to a well-diversified